Suppression of BCL3 led to the upregulation of TNF-alpha and IL-6 and the downregulation of IL-10 in MDA-MB-231 triple-negative breast cancer cells [111], all of which would theoretically stimulate the recruitment and activation of immune cells within the tumour microenvironment [129]. Here, BCL3 is linked to neoplasm.